NIH awards $850,000 biodefense grant to Durham, N.C., company

12/16/2008 | News & Observer (Raleigh, N.C.), The

The NIH has awarded an $850,000 grant to Parion Sciences to further its research on CF-552, a drug candidate for the prevention of radiation-induced lung injuries caused by adverse nuclear events. Previous studies have shown that the drug helps in clearing radioactive particles from the lungs.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN